DE
Destiny Pharma
DEST.L·LSEBrighton UKFounded 199615 employees
Micro CapbiotechPublicInfectious Disease
Platform: XF-73 Anti-staph
Market Cap
$0.01B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (DEST.L)
Loading DEST.L stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Voxasertib | DES-1901 | Phase 2/3 | 2 | APOC3 | Myelofibrosis | ||
| DES-7076 | DES-7076 | Phase 2 | 2 | CD123 | Urothelial Ca |
SEC Filings & Financial Documents
SEC filings are not available for LSE-listed companies.
Destiny Pharma trades on LSE (GB). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)